Fundz

Liberate Bio Appoints Steven H. Bernstein, M.D. as Chief Medical Officer

PRIVATEJul 28, 2026

Position

Chief Medical Officer

Company

Liberate Bio

Steven H. Bernstein, M.D.
BostonBiotechnologyHealth CareTherapeutics

Description

Liberate Bio, a leader in cell therapy, has appointed Steven H. Bernstein, M.D., as its Chief Medical Officer effective July 13, 2026. Dr

Quick answer

Liberate Bio Appoints Steven H. Bernstein, M.D. as Chief Medical Officer (July 28, 2026). Liberate Bio is based in Boston, Massachusetts, United States.

Who is the new Chief Medical Officer at Liberate Bio?
Liberate Bio named Steven H. Bernstein, M.D. Chief Medical Officer, announced July 28, 2026.
What did Liberate Bio announce on July 28, 2026?
Liberate Bio, a leader in cell therapy, has appointed Steven H. Bernstein, M.D., as its Chief Medical Officer effective July 13, 2026.
What does Liberate Bio do?
Liberate Bio, Inc. is a biotechnology company focused on developing genetic medicines that program immune cells directly inside the body.
Where is Liberate Bio based?
Liberate Bio is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Nasus Pharma (July 28, 2026), InstaMed Pharmaceuticals (July 27, 2026), AQTUAL (July 28, 2026) and Sarepta Therapeutics (July 27, 2026) also announced leadership changes within 45 days of Liberate Bio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Liberate Bio, and when

A new leader at Liberate Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Liberate Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Liberate Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Liberate Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Liberate Bio

Location

Boston, Massachusetts, United States

About

Liberate Bio, Inc. is a biotechnology company focused on developing genetic medicines that program immune cells directly inside the body. They are advancing innovative platforms for in vivo CAR-M programs towards clinical applications. The company aims to enhance patient access to cell therapies by overcoming manufacturing and delivery constraints.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Liberate Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Walter
Senior decision-maker at this company
••••••••@••••••••

See Walter's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Liberate Bio's next move

Learn about Strategic plan

Liberate Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.